RESULTS OF A PHASE I/II TRIAL OF 5 FRACTION STEREOTACTIC RADIOSURGERY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Azoulay, Melissa [1 ]
Fujimoto, Dylann [1 ]
Modlin, Leslie [1 ]
Ho, Clement [1 ]
Gibbs, Iris [1 ]
Hancock, Steven L. [1 ]
Li, Gordon [1 ]
Chang, Steven D. [1 ]
Adler, John R. [1 ]
Harsh, Griffith R. [1 ]
Harraher, Ciara [1 ]
Nagpal, Seema [1 ]
Thomas, Reena [1 ]
Vrecht, Lawrence [1 ]
Choi, Clara [2 ]
Soltys, Scott G. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Santa Clara Valley Med Ctr, San Jose, CA USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
37
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] A Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Azoulay, M.
    Ho, C. K.
    Fujimoto, D. K.
    Modlin, L. A.
    Gibbs, I. C.
    Hancock, S. L.
    Li, G.
    Chang, S. D.
    Adler, J. R., Jr.
    Harsh, G. R.
    Nagpal, S.
    Thomas, R.
    Recht, L.
    Choi, C. Y. H.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E131 - E132
  • [2] A Phase 1/2 Trial of 5 Fraction Stereotactic Radiosurgery With 5 mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme: Pattern of Recurrence Analysis
    Azoulay, M.
    Gibbs, I. C.
    Hancock, S. L.
    Ho, C. K.
    Fujimoto, D. K.
    Chang, S. D.
    Harsh, G.
    Nagpal, S.
    Thomas, R.
    Recht, L.
    Choi, C. Y. H.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S102 - S103
  • [3] A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery With 5MM Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Quality of Life and Updated Outcomes
    Pollom, Erqi
    Dudley, Sara
    Azoulay, Melissa
    Fujimoto, Dylann
    Wynne, Jacob
    Seiger, Kira
    Modlin, Leslie M.
    Jacobs, Lisa Rose
    Tupper, Laurie
    Gibbs, Iris
    Hancock, Steven
    Li, Gordon
    Chang, Steven
    Adler, John
    Harsh, Griffith
    Harraher, Ciara
    Nagpal, Seema
    Thomas, Reena
    Choi, Clara
    Soltys, Scott
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E19 - E20
  • [4] A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes
    Azoulay, Melissa
    Chang, Steven D.
    Gibbs, Iris C.
    Hancock, Steven L.
    Pollom, Erqi L.
    Harsh, Griffith R.
    Adler, John R.
    Harraher, Ciara
    Li, Gordon
    Gephart, Melanie Hayden
    Nagpal, Seema
    Thomas, Reena P.
    Recht, Lawrence D.
    Jacobs, Lisa R.
    Modlin, Leslie A.
    Wynne, Jacob
    Seiger, Kira
    Fujimoto, Dylann
    Usoz, Melissa
    von Eyben, Rie
    Choi, Clara Y. H.
    Soltys, Scott G.
    NEURO-ONCOLOGY, 2020, 22 (08) : 1182 - 1189
  • [5] Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results
    Pollom, Erqi L.
    Fujimoto, Dylann
    Wynne, Jacob
    Seiger, Kira
    Modlin, Leslie A.
    Jacobs, Lisa R.
    Azoulay, Melissa
    von Eyben, Rie
    Tupper, Laurie
    Gibbs, Iris C.
    Hancock, Steven L.
    Li, Gordon
    Chang, Steven D.
    Adler, John R.
    Harsh, Griffith R.
    Harraher, Ciara
    Nagpal, Seema
    Thomas, Reena P.
    Recht, Lawrence D.
    Choi, Clara Y. H.
    Soltys, Scott G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 123 - 130
  • [6] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [7] Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide
    Mendoza, Maria G.
    Azoulay, Melissa
    Chang, Steven D.
    Gibbs, Iris C.
    Hancock, Steven L.
    Pollom, Erqi L.
    Adler, John R.
    Harraher, Ciara
    Li, Gordon
    Gephart, Melanie Hayden
    Nagpal, Seema
    Thomas, Reena P.
    Recht, Lawrence D.
    Jacobs, Lisa R.
    Modlin, Leslie A.
    Wynne, Jacob
    Seiger, Kira
    Fujimoto, Dylann
    Usoz, Melissa
    von Eyben, Rie
    Choi, Clara Y. H.
    Soltys, Scott G.
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (03) : e239 - e245
  • [8] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
  • [9] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [10] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
12345